Noul Co

Noul Co Current Assets

The Current Assets of Noul Co (376930.KQ) as of Oct 30, 2026 is 4.56 B KRW. In the previous year, Current Assets was 27.95 B KRW — a change of -83.68% (lower).

Current Assets

4.56 BKRW

YoY

-83.68%

Last updated:

Current Assets of Noul Co is 2025 4.56 B KRW. Current Assets of Noul Co was 2024 27.95 B KRW. It decreases by -83.68% lower compared to the previous year.

The Noul Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
1.58 B KRW
Jan 1, 2020
9.56 B KRW
Jan 1, 2021
12.49 B KRW
Jan 1, 2022
13.84 B KRW
Jan 1, 2023
24.92 B KRW
Jan 1, 2024
27.95 B KRW
Jan 1, 2025
4.56 B KRW
The Noul Co Current Assets history
YEARCurrent AssetsYoY
4.56 BKRW-83.68%
27.95 BKRW+12.16%
24.92 BKRW+80.14%
13.84 BKRW+10.75%
12.49 BKRW+30.66%
9.56 BKRW+503.61%
1.58 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Noul Co Stock analysis

What does Noul Co do? Noul Co., Ltd. generates revenue through the manufacture and sale of blood test diagnostic devices utilizing AI algorithms and diagnostic kits. The company offers regular monthly subscriptions via its integrated web-based remote diagnosis system, targeting healthcare providers and medical facilities seeking advanced diagnostic solutions. Its core products include AI-based diagnostic devices and associated kits, sold directly to clinics and hospitals for use in blood testing procedures. The firm's services are designed to enhance diagnostic accuracy and efficiency through remote access and subscription models. The company's primary revenue streams stem from the sale of physical diagnostic devices and diagnostic kits, alongside recurring subscription fees for its web-based remote diagnosis platform. Healthcare institutions and medical professionals form the key customer segments, purchasing both the hardware and ongoing service access. Noul Co., Ltd. focuses on delivering AI-driven diagnostic tools that integrate seamlessly into existing healthcare workflows, emphasizing convenience and technological innovation for its clients. Noul Co., Ltd. operates exclusively within the healthcare diagnostics sector, providing AI-powered blood test solutions that combine hardware sales with subscription-based software services. The business model relies on initial device purchases followed by continuous revenue from monthly subscriptions, creating a sustainable income stream. This approach ensures long-term engagement with healthcare providers while maintaining a focus on cutting-edge diagnostic technology. Noul Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Noul Co stock

Current Assets of Noul Co is 4.56 B KRW in 2025.

Current Assets of Noul Co changed from 27.95 B KRW to 4.56 B KRW, representing a -83.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Noul Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Noul Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Noul Co

All Key Metrics — Noul Co